Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such as during car rides, boat trips, or flights. Motion sickness… Read more
Yartemlea (narsoplimab-wuug) is a new medicine approved by the FDA for treating a rare and serious condition called transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children ages 2 years or older. TA-TMA is a serious… Read more
Darzalex Faspro is an injectable medicine used to treat adults with multiple myeloma, a type of blood cancer, and light chain (AL) amyloidosis, a rare condition caused by the buildup of abnormal proteins in organs.… Read more
Sogroya (somapacitan-beco) is a long-acting form of human growth hormone. You take it as a shot under the skin (subcutaneous) one time each week. It attaches to growth hormone receptors and triggers effects in the… Read more
Yuviwel (navepegritide) is a once-weekly shot for children 2 and older with achondroplasia who still have open growth plates. It is approved by the FDA to help increase height in this group. Yuviwel is a… Read more
Yuvezzi is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you age. It’s the only FDA-approved eye drop that combines two… Read more
Rybrevant Faspro is an under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has approved a new monthly dosing option for Rybrevant Faspro to be used in combination with the oral… Read more
Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP). The FDA has approved Cablivi to be used along with plasma exchange and immunosuppressive… Read more
Accrufer (ferric maltol) is an oral capsule approved by the FDA to treat iron deficiency in kids ages 10 years and older. It helps your body absorb iron through your digestive system, which is important… Read more
Jascayd (nerandomilast) is now approved for treating adults with progressive pulmonary fibrosis (PPF) that causes gradual and permanent scarring in the lungs, making it harder to breathe over time. Jascayd was previously approved to treat… Read more